Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

STING agonists activate latently infected cells and enhance SIV-specific responses ex vivo in naturally SIV controlled cynomolgus macaques.

Yamamoto T, Kanuma T, Takahama S, Okamura T, Moriishi E, Ishii KJ, Terahara K, Yasutomi Y.

Sci Rep. 2019 Apr 11;9(1):5917. doi: 10.1038/s41598-019-42253-3.

2.

A unique nanoparticulate TLR9 agonist enables a HA split vaccine to confer FcγR-mediated protection against heterologous lethal influenza virus infection.

Yamamoto T, Masuta Y, Momota M, Kanekiyo M, Kanuma T, Takahama S, Moriishi E, Yasutomi Y, Saito T, Graham BS, Takahashi Y, Ishii KJ.

Int Immunol. 2019 Feb 15;31(2):81-90. doi: 10.1093/intimm/dxy069.

PMID:
30535055
3.

An Antigen-Free, Plasmacytoid Dendritic Cell-Targeting Immunotherapy To Bolster Memory CD8+ T Cells in Nonhuman Primates.

Masuta Y, Yamamoto T, Natsume-Kitatani Y, Kanuma T, Moriishi E, Kobiyama K, Mizuguchi K, Yasutomi Y, Ishii KJ.

J Immunol. 2018 Mar 15;200(6):2067-2075. doi: 10.4049/jimmunol.1701183. Epub 2018 Feb 5.

4.

CD63-Mediated Antigen Delivery into Extracellular Vesicles via DNA Vaccination Results in Robust CD8+ T Cell Responses.

Kanuma T, Yamamoto T, Kobiyama K, Moriishi E, Masuta Y, Kusakabe T, Ozasa K, Kuroda E, Jounai N, Ishii KJ.

J Immunol. 2017 Jun 15;198(12):4707-4715. doi: 10.4049/jimmunol.1600731. Epub 2017 May 15.

5.

Efficacy and safety of live varicella zoster vaccine in diabetes: a randomized, double-blind, placebo-controlled trial.

Hata A, Inoue F, Hamamoto Y, Yamasaki M, Fujikawa J, Kawahara H, Kawasaki Y, Honjo S, Koshiyama H, Moriishi E, Mori Y, Ohkubo T.

Diabet Med. 2016 Aug;33(8):1094-101. doi: 10.1111/dme.13038. Epub 2015 Dec 29.

PMID:
26605507
6.

Safety, humoral and cell-mediated immune responses to herpes zoster vaccine in subjects with diabetes mellitus.

Hata A, Inoue F, Yamasaki M, Fujikawa J, Kawasaki Y, Hamamoto Y, Honjo S, Moriishi E, Mori Y, Koshiyama H.

J Infect. 2013 Sep;67(3):215-9. doi: 10.1016/j.jinf.2013.04.010. Epub 2013 Apr 18.

PMID:
23603250
7.

Influenza virus neuraminidase contributes to the dextran sulfate-dependent suppressive replication of some influenza A virus strains.

Yamada H, Moriishi E, Haredy AM, Takenaka N, Mori Y, Yamanishi K, Okamoto S.

Antiviral Res. 2012 Dec;96(3):344-52. doi: 10.1016/j.antiviral.2012.09.012. Epub 2012 Sep 26.

PMID:
23022352
8.

A community-based survey of varicella-zoster virus-specific immune responses in the elderly.

Tang H, Moriishi E, Okamoto S, Okuno Y, Iso H, Asada H, Yamanishi K, Mori Y; Shozu Herpes Zoster Study group.

J Clin Virol. 2012 Sep;55(1):46-50. Epub 2012 Jul 6.

PMID:
22771002
9.

Human herpesvirus-6 induces MVB formation, and virus egress occurs by an exosomal release pathway.

Mori Y, Koike M, Moriishi E, Kawabata A, Tang H, Oyaizu H, Uchiyama Y, Yamanishi K.

Traffic. 2008 Sep;9(10):1728-42. doi: 10.1111/j.1600-0854.2008.00796.x. Epub 2008 Jul 11.

10.

Microtubule network facilitates nuclear targeting of human cytomegalovirus capsid.

Ogawa-Goto K, Tanaka K, Gibson W, Moriishi E, Miura Y, Kurata T, Irie S, Sata T.

J Virol. 2003 Aug;77(15):8541-7.

11.

Preincubation of recombinant Ipa proteins of Shigella sonnei promotes entry of non-invasive Escherichia coli into HeLa cells.

Terajima J, Moriishi E, Kurata T, Watanabe H.

Microb Pathog. 1999 Oct;27(4):223-30.

PMID:
10502463
12.

Infection of a human retinal pigment epithelial cell line with human herpesvirus 6 variant A.

Arao Y, Soushi S, Sato Y, Moriishi E, Ando Y, Yamada M, Padilla J, Uno F, Nii S, Kurata T.

J Med Virol. 1997 Oct;53(2):105-10.

PMID:
9334920

Supplemental Content

Loading ...
Support Center